NCT06774729Recruiting
Development of a Radiomics Model With MR to Predict the Occurence of a Infiltration of Muscoskeletal Tumor
Development of a Radiomics Model With 3T Multiparametric MR to Predict the Occurence of a Perilesional Infiltration of Muscoskeletal Tumor During the Pre- Surgery Planning
Source: ClinicalTrials.gov · Last updated 14 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The goal of this observational study is to evaluate the feasibility and clinical utility of radiomics to diagnose peri-lesion tumour infiltration of tumours in participants with a suspect of Bone Cancer Tumor or Soft Tissue Sarcoma (STS). The main questions it aims to answer are: * is radiomics able to identify the ratio of participants truly diagnosed as positive to all those who had positive test results? * is radiomics able to identify the likelihood that a participant who has a negative test result indeed does not have the disease? Participants eligible for this study will get a MRI as part of their regular medical care. The only difference is that their data will be recorded and anonymously analyzed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 122 (estimated)
- First submitted
- 9 Jan 2025
- Start date
- Mar 2025
- Primary completion date
- Sept 2028
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Diseases
- Sarcoma
- NCT number
- NCT06774729
What you commit to
- Study type: Observational
- Planned participants: 122
- From Mar 2025 to the primary completion date, Sept 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- simultaneous cancer or history of cancer in the last 5 years
- acute or chronic serious conditions that could
- contraindication to conduct a Contrast-enhanced magnetic resonance imaging (MRI) such as:
- renal failure without dialysis
- history of allergy to a paramagnetic contrast agent
- claustrophobia
- symptomatic epilepsy or history of epilepsy
- cardiac pacemaker
- infusion pump, prosthesis or any implant not compatible with MRI
- pregnancy
Who the study is looking for
- Age over 18
- suspect of soft tissue sarcoma with a indication for surgical treatment
- suspect of bone cancer tumor with a indication for surgical treatment
- To give informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna Coordinator of this site? Confirm its status | Bologna | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.